Latest Breaking News On - Institutional investors weigh in on eyepoint pharmaceuticals - Page 1 : comparemela.com

Analysts Set EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Target Price at $34 00

Analysts Set EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Target Price at $34 00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Securities exchange commissionHermes incInsider activity at eyepoint pharmaceuticalsEyepoint pharmaceuticals incFranklin resources incAnalyst recommendations for eyepoint pharmaceuticalsEyepoint pharmaceuticals price performanceNews ratings for eyepoint pharmaceuticals dailyJennison associatesJpmorgan chase coEyepoint pharmaceuticals company profileVanguard group incInstitutional investors weigh in on eyepoint pharmaceuticalsEyepoint pharmaceuticalsGet free reportOne financial

StockNews com Downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to Sell

StockNews com Downgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to Sell
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Vanguard group incHermes incEyepoint pharmaceuticalsEyepoint pharmaceuticals incJennison associatesInstitutional investors weigh in on eyepoint pharmaceuticalsSecurities exchange commissionJpmorgan chase coEyepoint pharmaceuticals company profileEyepoint pharmaceuticals stock downNews ratings for eyepoint pharmaceuticals dailyAnalyst recommendations for eyepoint pharmaceuticalsFranklin resources incFree reportOne financialModerate buy

Chardan Capital Comments on EyePoint Pharmaceuticals, Inc s FY2025 Earnings (NASDAQ:EYPT)

Chardan Capital Comments on EyePoint Pharmaceuticals, Inc s FY2025 Earnings (NASDAQ:EYPT)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesEyepoint pharmaceuticals incInsider transactions at eyepoint pharmaceuticalsInstitutional investors weigh in on eyepoint pharmaceuticalsProshare advisorsLegacy capital group california incNews ratings for eyepoint pharmaceuticals dailyEyepoint pharmaceuticals stock performanceSwiss national bankEssex investment management coJpmorgan chase coEyepoint pharmaceuticalsFree reportChardan capitalEyepoint pharmaceuticalOne financial

EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Major Shareholder Cormorant Asset Management, Lp Buys 850,000 Shares of Stock

EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Major Shareholder Cormorant Asset Management, Lp Buys 850,000 Shares of Stock
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdInvestment advisersNews ratings for eyepoint pharmaceuticals dailyEyepoint pharmaceuticals price performanceSecurities exchange commissionInstitutional investors weigh in on eyepoint pharmaceuticalsProshare advisorsToth financial advisory corpTower research capitalEyepoint pharmaceuticals incChina universal asset management coEyepoint pharmaceuticals company profileQuarter for eyepoint pharmaceuticalsJpmorgan chase coEyepoint pharmaceuticalsGet free report

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up Following Insider Buying Activity
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Darioa paggiarinoFranklin resources incFirst turn managementNews ratings for eyepoint pharmaceuticals dailyEyepoint pharmaceuticalsSecurities exchange commissionJpmorgan chase coEyepoint pharmaceuticals incEyepoint pharmaceuticals stockInstitutional investors weigh in on eyepoint pharmaceuticalsHermes incJennison associatesGet free reportPoint pharmaceuticalsExchange commissionCormorant asset management